Julie Van Ongevalle
Julie Van Ongevalle is the CEO of Opella, a pharmaceutical company that produces popular over-the-counter medications including Doliprane. She has been in the news following the announcement of Opella's official separation from Sanofi, where she assured stakeholders that the production of Doliprane would remain in France despite new American ownership.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Monaco:
Julie Van Ongevalle is the CEO of Opella and assured that Doliprane will remain in France for the French.
8